Auxilium Pharmaceuticals Inc (AUXL) shares are trading up more than 11% in Thursday’s pre-market session after the company announced today that it has agreed to be acquired by Endo International (ENDP) for about $2.6 billion, including the assumption of debt. Auxilium terminated its prior merger agreement with Canada’s QLT (QLTI) as a result of the Endo deal.
ENDP will pay $33.25 a share, and Auxilium stockholders will be able to choose cash and stock, all-stock or all-cash consideration, subject to proration in accordance with the terms of the definitive agreement, the companies said in a statement. The per share consideration represents a premium of 55% to AUXL’s closing PPS on Sept. 16, 2014, the day Endo made public its proposal for Auxilium.
“We are pleased to have reached this agreement with Auxilium, which we believe will create value for both Endo and Auxilium shareholders, as well as for patients, customers and employees,” Endo Chief Executive Officer Rajiv De Silva said in a press release.
On valuation measures, Auxilium Pharmaceuticals, currently valued at $1.50B, has a median Wall Street price target of $32.00 with a high target of $37.00. Approximately 2,037,461 shares changed hands during Wednesday’s session compared to the stock’s average daily volume of 1,463,120.
In the past 52 weeks, shares of Chesterbrook, Pennsylvania-based specialty biopharmaceutical company have traded between a low of $16.36 and a high of $32.89 with the 50-day MA and 200-day MA located at $24.73 and $22.64 levels, respectively. Additionally, shares of AUXL trade at a P/E ratio of -2.95 and have a Relative Strength Index (RSI) and MACD indicator of 66.91 and -0.52, respectively.
AUXL currently prints a one year return of about 70.64% and a year-to-date return of around 43.56%.
Apple (AAPL) shares were slightly lower in premarket trade on news that the tech giant has pushed back plans to produce a larger-screen iPad until early next year due to overwhelming demand for the company’s latest iPhones. Suppliers of the Cupertino, Calif.-based company had originally planned to produce the larger tablet in mass volume beginning in December. Separately, AAPL was upgraded to ‘Outperform’ from ‘Perform’ at Oppenheimer this morning with the firm attributing the upgrade on the strength of the iPhone maker’s latest upgrade cycle. The firm put a $115 price target on shares implying 13% expected return.
On valuation-measures, shares of Apple have a trailing-12 and forward P/E of 16.26 and 13.83, respectively. P/E to growth ratio is 1.30, while t-12 profit margin is 21.64%. EPS registers at $6.20. The company has a market cap of $603.58B and a median Wall Street price target of $110.00 with a high target of $135.00. Currently there are 31 analysts that rate AAPL a ‘Buy’, 11 rate it a ‘Hold’ and 2 rate it a ‘Sell’.
On trading-measure, AAPL has a beta of 1.03 and a short float of 2.31%. In the past 52 weeks, shares of the tech giant have traded between a low of $69.31 and a high of $103.74 with the 50-day MA and 200-day MA located at $100.61 and $91.40 levels, respectively.
AAPL currently prints a one year return of about 50.02% and a year-to-date return of around 27.87%. Ticker is down $0.13 to $100.67 in pre-market trading today.
Google (GOOG) is asking the Supreme Court to weigh in on the legality of a high-profile copyright lawsuit filed against the search giant by Oracle Corp. (ORCL) 4 years ago over the Java programming language, which Google uses in its Android OS. The company is asking the court to overturn a ruling made by an appeals court that found Google guilty of copyright infringement.
On valuation measures, Google shares are currently priced at 29.66x this year’s forecasted earnings compared to the industry’s 9.01x earnings multiple. Ticker has a PEG and forward P/E ratio of 1.35 and 19.05, respectively. Price/Sales for the same period is 5.85 while EPS is $19.30. Currently there are 34 analysts that rate GOOG a ‘Buy’, while 8 rate it a ‘Hold’. No analysts rate it a ‘Sell’. GOOG has a median Wall Street price target of $672.00 with a high target of $750.00.
In the past 52 weeks, shares of Mountain View, California-based company have traded between a low of $502.80 and a high of $604.83 and are now at $570.69. Shares are up 31.39% year-over-year and 2.27% year-to-date.
Microsoft Corporation (MSFT) is currently changing hands at $46.59, down 0.41%, on news the company is planning to cancel its Surface Pro 3 product line due to weaker than expected sales. According to DigiTimes sources, “the first- and second-generation Surface tablets are estimated to have created losses of about $1.7 billion.”
On valuation measures, Microsoft Corporation shares are currently priced at 17.79x this year’s forecasted earnings compared to the industry’s 9.01x earnings multiple. Ticker has a PEG and forward P/E ratio of 2.40 and 14.62, respectively. Price/Sales for the same period is 4.32 while EPS is $2.63. Currently there are 14 analysts that rate MSFT a ‘Buy’, while 18 rate it a ‘Hold’. 1 analyst rates it a ‘Sell’. MSFT has a median Wall Street price target of $50.00 with a high target of $56.00.
In the past 52 weeks, shares of the software giant have traded between a low of $33.26 and a high of $47.57 and are now at $46.65. Shares are up 45.78% year-over-year and 27.67% year-to-date.
Alcoa Inc. (AA) shares were 1.62% higher in premarket trade after the largest U.S. aluminum producer reported Q3 profit excluding one-time items of 31 cents per share, beating estimates by eight cents. Sales also beat estimates, with Alcoa’s Q3 revs climbing 7% sequentially and 8% y/y to $6.2 billion. The results were helped by higher aluminum prices and lower costs.
On valuation measures, Alcoa has a PEG and forward P/E ratio of 0.50 and 16.74, respectively. Price/Sales for the same period is 0.83 while EPS is ($2.15). Currently there are 8 analysts that rate AA a ‘Buy’, while 9 rate it a ‘Hold’. 2 analysts rate it a ‘Sell’. AA has a median Wall Street price target of $17.00 with a high target of $24.50.
In the past 52 weeks, shares of New York-based company have traded between a low of $8.16 and a high of $17.36 and are now at $16.28. Shares are up 104.45% year-over-year and 52.18% year-to-date.